125 related articles for article (PubMed ID: 18308013)
1. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
Tribouilloy C; Rusinaru D; Leborgne L; Peltier M; Massy Z; Slama M
Am J Cardiol; 2008 Mar; 101(5):639-44. PubMed ID: 18308013
[TBL] [Abstract][Full Text] [Related]
2. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
3. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
Ahmed A; Centor RM; Weaver MT; Perry GJ
Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
[TBL] [Abstract][Full Text] [Related]
4. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study.
Tribouilloy C; Rusinaru D; Mahjoub H; Tartière JM; Kesri-Tartière L; Godard S; Peltier M
Heart; 2008 Nov; 94(11):1450-5. PubMed ID: 18208832
[TBL] [Abstract][Full Text] [Related]
7. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
8. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
[TBL] [Abstract][Full Text] [Related]
9. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
10. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
11. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376
[TBL] [Abstract][Full Text] [Related]
12. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
[TBL] [Abstract][Full Text] [Related]
13. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
[TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community.
Rochon PA; Sykora K; Bronskill SE; Mamdani M; Anderson GM; Gurwitz JH; Gill S; Tu JV; Laupacis A
J Gen Intern Med; 2004 Jun; 19(6):676-83. PubMed ID: 15209607
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
16. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
Andersson B; Kjörk E; Brunlöf G
Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
19. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
20. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge.
Butler J; Arbogast PG; Daugherty J; Jain MK; Ray WA; Griffin MR
J Am Coll Cardiol; 2004 Jun; 43(11):2036-43. PubMed ID: 15172409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]